A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.
about
Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report.Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.Necrotizing fungal gingivitis in a patient with Acute Myelogenous Leukemia: visible yet obscure.Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis.
P2860
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A cohort study on breakthrough ...... eiving antifungal prophylaxis.
@en
A cohort study on breakthrough ...... eiving antifungal prophylaxis.
@nl
type
label
A cohort study on breakthrough ...... eiving antifungal prophylaxis.
@en
A cohort study on breakthrough ...... eiving antifungal prophylaxis.
@nl
prefLabel
A cohort study on breakthrough ...... eiving antifungal prophylaxis.
@en
A cohort study on breakthrough ...... eiving antifungal prophylaxis.
@nl
P2093
P2860
P356
P1476
A cohort study on breakthrough ...... eiving antifungal prophylaxis.
@en
P2093
Bernd Franke
Birgid Markiefka
Blasius Liss
Christof Scheid
Hilmar Wisplinghoff
J Janne Vehreschild
Lena M Biehl
Maria J G T Vehreschild
Thorsten Persigehl
Vanessa Bücker
P2860
P304
P356
10.1093/JAC/DKW199
P407
P577
2016-06-17T00:00:00Z